Adams Looks To Mucinex Extensions; “Mr. Mucus” Marries
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics sees additions to its Mucinex extended-release guaifenesin line as "key" to the firm's long-term growth strategy
You may also be interested in...
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006
Adams Rounds Out Mucinex Brand With Line Extension Approval
FDA approval of Adams Respiratory Therapeutics' Mucinex D gives the firm another brand line extension to compete in the crowded OTC cough/cold market
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation